Pfiz­er inks $60M set­tle­ment to close Nurtec an­ti-kick­back suit

Pfiz­er will pay near­ly $60 mil­lion to set­tle claims that its sub­sidiary Bio­haven used il­le­gal kick­backs to dri­ve sales of its mi­graine med­i­cine Nurtec ODT …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland